Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) fell 10.7% during mid-day trading on Monday . The company traded as low as C$0.12 and last traded at C$0.12. 252,156 shares were traded during trading, an increase of 149% from the average daily volume of 101,128 shares. The stock had previously closed at C$0.14.
Voyageur Pharmaceuticals Stock Performance
The company has a market capitalization of C$22.43 million, a price-to-earnings ratio of -12.50 and a beta of 0.78. The company has a 50 day moving average price of C$0.10 and a 200 day moving average price of C$0.13. The company has a debt-to-equity ratio of 6.05, a quick ratio of 0.84 and a current ratio of 0.18.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
